This inventor holds 1 USPTO granted patent. Top assignee: Weifang Medical University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Linyue Liu: Innovator in Anti-HBV Pharmaceutical Development
Introduction
Linyue Liu is a notable inventor based in Weifang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-HBV (hepatitis B virus) treatments. His innovative work has the potential to impact the lives of many individuals affected by this virus.
Latest Patents
Linyue Liu holds a patent for a sulfonamide benzamide derivative, which is a promising pharmaceutical composition for combating HBV. The patent describes a preparation method that involves sulfonation, acylation, and sulfonylation reactions. This sulfonamide benzamide derivative has demonstrated effective activity against HBV by inhibiting HBV DNA replication in vitro. He has 1 patent to his name, showcasing his dedication to advancing medical science.
Career Highlights
Linyue Liu is affiliated with Weifang Medical University, where he contributes to research and development in the pharmaceutical field. His work is characterized by a commitment to innovation and improving health outcomes for patients suffering from viral infections.
Collaborations
Linyue Liu has collaborated with esteemed colleagues such as Haiyong Jia and Chuanju Li. These partnerships enhance the research efforts and broaden the impact of their collective work in the medical community.
Conclusion
Linyue Liu's contributions to the development of anti-HBV pharmaceuticals highlight his role as an important inventor in the field. His innovative approaches and collaborations pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile